WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Jonathan Soderstrom
Chief Licensing Advisor
Life Sciences Business Advisory Practice
New York
jsoderstrom@wsgr.com

D203-314-9103

Download vCard
Open PDF

Dr. Jonathan Soderstrom is a chief licensing advisor in the New York office of Wilson Sonsini Goodrich & Rosati. He is also a member of the technology transactions and the patents and innovations practice groups. Jon has spent over 40 years managing the commercialization of intellectual property created at major public and private research institutions.

Under Jon’s leadership for 25-plus years, Yale Ventures (formerly known as Yale’s Office of Cooperative Research) helped form over 75 new ventures including Achillion Pharmaceuticals, Arvinas, NextCure, Biohaven Pharmaceuticals, and Inozyme Pharma, which have collectively raised over $1 billion in professional venture capital.

In 2001, with his direction, Yale became the first university to monetize its intellectual property when it worked with Royalty Pharma to sell its royalty interest in Zerit®, the first FDA-approved drug to effectively treat HIV/AIDS. In 2007, his office created the Tsai Center for Innovative Thinking at Yale (formerly known as the Yale Entrepreneurial Institute) to help undergraduate, graduate, and professional school students at Yale to start scalable new ventures. Over 100 new ventures were formed that raised over $135 million in investment capital, including IsoPlexis. In 2009, together with seven other major research universities, Jon helped lead the formation of Osage University Partners to invest in the participation rights that universities acquire in their start-up ventures based on their intellectual property. In 2016, he helped create the Academic Venture Exchange designed to connect highly successful serial entrepreneurs with start-up opportunities at major research universities.

Earlier in his career, Jon served as a director of program development and externally sponsored research at Oak Ridge National Laboratory, where he negotiated the first patent license and Cooperative Research and Development Agreements from a National Laboratory to a commercial partner.

Jon has served in a number of professional leadership positions and is well-known in his community and industry. In addition to his professional accomplishments, he was honored as the 87th “Point of Light” by President George H.W. Bush in March 1990 for volunteer work with low-income families in East Tennessee through the creation of Aid to Distressed Families of Appalachian Counties.

Experience

Dr. Jonathan Soderstrom is a chief licensing advisor in the New York office of Wilson Sonsini Goodrich & Rosati. He is also a member of the technology transactions and the patents and innovations practice groups. Jon has spent over 40 years managing the commercialization of intellectual property created at major public and private research institutions.

Under Jon’s leadership for 25-plus years, Yale Ventures (formerly known as Yale’s Office of Cooperative Research) helped form over 75 new ventures including Achillion Pharmaceuticals, Arvinas, NextCure, Biohaven Pharmaceuticals, and Inozyme Pharma, which have collectively raised over $1 billion in professional venture capital.

In 2001, with his direction, Yale became the first university to monetize its intellectual property when it worked with Royalty Pharma to sell its royalty interest in Zerit®, the first FDA-approved drug to effectively treat HIV/AIDS. In 2007, his office created the Tsai Center for Innovative Thinking at Yale (formerly known as the Yale Entrepreneurial Institute) to help undergraduate, graduate, and professional school students at Yale to start scalable new ventures. Over 100 new ventures were formed that raised over $135 million in investment capital, including IsoPlexis. In 2009, together with seven other major research universities, Jon helped lead the formation of Osage University Partners to invest in the participation rights that universities acquire in their start-up ventures based on their intellectual property. In 2016, he helped create the Academic Venture Exchange designed to connect highly successful serial entrepreneurs with start-up opportunities at major research universities.

Earlier in his career, Jon served as a director of program development and externally sponsored research at Oak Ridge National Laboratory, where he negotiated the first patent license and Cooperative Research and Development Agreements from a National Laboratory to a commercial partner.

Jon has served in a number of professional leadership positions and is well-known in his community and industry. In addition to his professional accomplishments, he was honored as the 87th “Point of Light” by President George H.W. Bush in March 1990 for volunteer work with low-income families in East Tennessee through the creation of Aid to Distressed Families of Appalachian Counties.

Education
  • Ph.D., Northwestern University
  • B.A., Hope College

    Magna Cum Laude

Associations and Memberships
  • Advisory Board Member, LevelSet Capital
  • Steering Board Member, Eshelman Institute for Innovation
  • Member Board of Trustees, Hope College
  • Founding Board Member and Former President, Association of Federal Technology Transfer Executives
  • Former President (2008), former Vice President for Public Policy (2003-2005), and former member of the Executive Committee of the Board of Directors for the Association of University Technology Managers (AUTM)
Honors
  • Recipient, Bayh-Dole Award, 2014
  • Named a “Healthcare Hero Person of Merit” by Business New Haven Magazine, 2012
  • Recipient, Distinguished Alumni Award, Hope College, 2011
  • Recipient, Atlas Award for Venture Capital Achievement, Connecticut United for Research Excellence, 2010
  • Recipient, Yale/Seton Elm-Ivy Award, Community Foundation of Greater New Haven, 1999
  • Honored as the 87th “Point of Light” by President George H.W. Bush for volunteer community service, 1990
Credentials
Education
  • Ph.D., Northwestern University
  • B.A., Hope College

    Magna Cum Laude

Associations and Memberships
  • Advisory Board Member, LevelSet Capital
  • Steering Board Member, Eshelman Institute for Innovation
  • Member Board of Trustees, Hope College
  • Founding Board Member and Former President, Association of Federal Technology Transfer Executives
  • Former President (2008), former Vice President for Public Policy (2003-2005), and former member of the Executive Committee of the Board of Directors for the Association of University Technology Managers (AUTM)
Honors
  • Recipient, Bayh-Dole Award, 2014
  • Named a “Healthcare Hero Person of Merit” by Business New Haven Magazine, 2012
  • Recipient, Distinguished Alumni Award, Hope College, 2011
  • Recipient, Atlas Award for Venture Capital Achievement, Connecticut United for Research Excellence, 2010
  • Recipient, Yale/Seton Elm-Ivy Award, Community Foundation of Greater New Haven, 1999
  • Honored as the 87th “Point of Light” by President George H.W. Bush for volunteer community service, 1990
Focus Areas
  • Life Sciences
  • Life Sciences Business Advisory Practice
  • Technology Transactions
Recent Events
Affiliated Programs
North Carolina Biotech Center – Wilson Sonsini Life Science Bootcamp
Wilson Sonsini is pleased to partner with the North Carolina Biotechnology Center to host a Life Science Bootcamp. Join us on October 27 for an event that will highlight practical insights into crucial legal and business matters for life science entrepreneurs. Attendees will gain expertise in key areas such as IP and licensing strategy, market-oriented patent and trade secret approaches, competitor analysis, in-licensing of enabling technologies, and collaborative IP structures.
Learn More
WSGR Events
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2022’s fundraising and deals, and how 2023 is shaping up along with partnering strategies in the current market.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.